About us

Dipharma is a global Contract Development and Manufacturing Organisation (CDMO) and a leading manufacturer of Active Pharmaceutical Ingredients, with more than 500 employees, 4 cGMP plants and commercial offices in Italy, U.S.A. and China.

We put our heart and soul into supporting our customers with a competitive and highly proactive approach, backed by 75 years of experience in safely handling hazardous chemical processes using state-of-the-art technologies.

As a third-generation family-owned company, we have a long history of stability, commitment and financial solidity.

We know how to deliver on creative innovation and we understand the critical importance of matching timelines, while operating in full respect of international regulations, Intellectual Property and third-party patents.

EXPERIENCE YOU CAN TRUST

Research and Development: We innovate by developing new processes by applying the latest methods and technologies to the existing ones.

Our Values

Behaviour Based Safety (BBS)

Reporting of Near Miss and Safety concerns

Root Cause Analysis (RCA), Failure Mode and Effects Analysis (FMEA)

GMP, inspected by US-FDA, AIFA, PMDA, etc. since 1970

Six Sigma (black and green belts)

Root Cause Analysis (RCA) and Error proof systems

Lean program, continuous improvement, Value Stream Mapping

Debottlenecking

Process Technologists

Intellectual Property (IP) department

A 250 patents/applications filed and more than 1200 scientific papers

Suggestion system

Broad range of technologies and production scale

Products validated on 2 mfg. sites

Insourcing/outsourcing of intermediates

Loyal customers

Loyal employees

Loyal shareholders

Our Code of Ethics

Dipharma is an organization with strong values of responsibility and integrity.

As a company with businesses and operations in several countries, we have a global responsibility to ensure proper conduct and, for that reason, we have decided to adopt a common Code of Ethics that contains the general guidelines for managing our business and that of our branches.

Our history

Corporate Governance

Dipharma is committed to ensuring good corporate governance because we believe that good corporate
governance benefits all stakeholders, whether they are customers, suppliers, employees, or shareholders.

The Board of Directors

The Board of Directors of Dipharma Francis S.r.l. is comprised of 4 members.
The Board of Directors is responsible for defining the strategic business guidelines
and monitoring operational management. The Board consists of non-executive
directors with industry expertise and specific technical skills.

Marc-Olivier
Geinoz

Chairman

Jorge
Nogueira

Chief Executive
Officer

Marco
Magnani

Non-Executive
Director

Enrico
Polastro

Non-Executive
Director

Management Team

Our management team is made up of skilled managers with extensive experience in the areas in which they operate.
They combine in-depth industry knowledge with strong leadership and long-term commitment to create innovative competitive solutions for our customers.

Jorge
Nogueira

CEO

Lorenzo
Brina

Global Director
of HR
& Gen. Services

Domenico
Chilà

Global COO

Mario
Cacciatore

Global CFO

Andrea
Confetti

Exclusive
Synthesis
BU Leader

Brian
Eklov

Dipharma Inc.
CEO

Alberto
Faido

Global Director
of Sales

Roberto
Fanelli

Catalogue APIs
BU Leader

Sabrina
Furin

Director of Corporate QA & RA

Fabrizio
Losi

Global Director
of ICT

Gabriele
Razzetti

Global Director
of R&D

Tiziana
Spaccasassi

Global Director of Supply Chain

Management Team

Our management team is composed by skilled managers with an extensive experience in the areas where they operate. They combine in-depth industry knowledge with strong leadership and long-term commitment to create innovative competitive solutions to our customers.

Jorge
Nogueira

CEO

Lorenzo
Brina

Global Director of HR & Gen. Services

Domenico
Chilà

Global COO

Mario
Cacciatore

Global CFO

Andrea
Confetti

Exclusive Synthesis BU Leader

Brian
Eklov

Dipharma Inc. CEO

Alberto
Faido

Global Director of Sales

Roberto
Fanelli

Catalogue APIs BU Leader

Sabrina
Furin

Director of Corporate QA & RA

Fabrizio
Losi

Global Director of ICT

Gabriele
Razzetti

Global Director of R&D

Tiziana
Spaccasassi

Global Director of Supply Chain